Search Count: 74
 |
Crystal Structure Of Wild Type Human Mitochondrial 2-Enoyl Thioester Reductase (Mecr)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-06-01 Classification: OXIDOREDUCTASE Ligands: CL, PO4, GOL, ACY |
 |
Crystal Structure Of Human Mitochondrial 2-Enoyl Thioester Reductase (Mecr) With Single Mutation G165Q
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-01 Classification: OXIDOREDUCTASE Ligands: CL |
 |
Organism: Streptococcus pyogenes m49 591
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-03-16 Classification: OXIDOREDUCTASE Ligands: SO4, GOL |
 |
Organism: Streptococcus pyogenes m49 591
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2022-03-16 Classification: OXIDOREDUCTASE Ligands: BME, SO4, GOL |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 6-[4-(3-Methanesulfonyl-Benzylamino)-5-Trifluoromethyl-Pyrimidin-2-Ylamino]-3,4-Dihydro-1H-Quinolin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.36 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P4N |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(3-{[2-(2-Oxo-1,2,3,4-Tetrahydro-Quinolin-6-Ylamino)-5-Trifluoromethyl-Pyrimidin-4-Ylamino]-Methyl}-Pyridin-2-Yl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P7N, NA, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(2-{[2-(2-Oxo-2,3-Dihydro-1H-Indol-5-Ylamino)-5-Trifluoromethyl-Pyrimidin-4-Ylamino]-Methyl}-Phenyl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P9K |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-(3-{[2-(2-Oxo-2,3-Dihydro-1H-Indol-5-Ylamino)-Pyrimidin-4-Ylamino]-Methyl}-Pyridin-2-Yl)-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: PKE, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 5-{4-[(Pyridin-3-Ylmethyl)-Amino]-5-Trifluoromethyl-Pyrimidin-2-Ylamino}-1,3-Dihydro-Indol-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: PVT, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With 4-{[4-{[(1R,2R)-2-(Dimethylamino)Cyclopentyl]Amino}-5-(Trifluoromethyl)Pyrimidin-2-Yl]Amino}-N-Methylbenzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: P1E, SO4 |
 |
Focal Adhesion Kinase Catalytic Domain In Complex With N-Methyl-N-{3-[(2-Phenylamino-5-Trifluoromethyl-Pyrimidin-4-Ylamino)-Methyl]-Pyridin-2-Yl}-Methanesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2021-02-10 Classification: TRANSFERASE Ligands: Q2H, SO4 |
 |
Organism: Trypanosoma brucei brucei
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2020-07-15 Classification: OXIDOREDUCTASE Ligands: NAP, ACT, KM5, GOL |
 |
Organism: Trypanosoma brucei brucei
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2020-07-15 Classification: OXIDOREDUCTASE Ligands: NAP, FE1, GOL, ACT |
 |
Organism: Trypanosoma brucei brucei
Method: X-RAY DIFFRACTION Resolution:1.11 Å Release Date: 2020-07-15 Classification: OXIDOREDUCTASE Ligands: NAP, KMK, ACT |
 |
Leishmania Major Pteridine Reductase 1 (Lmptr1) In Complex With Inhibitor 4 (Nmt-C0026)
Organism: Leishmania major
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2020-07-15 Classification: OXIDOREDUCTASE Ligands: NDP, KMK |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: B5Q |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: PU1 |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: P4A, SO4 |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: BAW |
 |
Estimation Of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2018-05-30 Classification: CHAPERONE Ligands: BA8 |